Advanced Medical Solutions Group’s (AMS) “Buy” Rating Reaffirmed at Berenberg Bank

Berenberg Bank restated their buy rating on shares of Advanced Medical Solutions Group (LON:AMS) in a research report sent to investors on Wednesday, MarketBeat Ratings reports. The firm currently has a GBX 300 ($3.96) price target on the stock.

Advanced Medical Solutions Group Stock Down 8.2 %

Advanced Medical Solutions Group stock opened at GBX 225 ($2.97) on Wednesday. The business has a fifty day moving average of GBX 240.06 and a two-hundred day moving average of GBX 216.34. The company has a quick ratio of 4.58, a current ratio of 5.67 and a debt-to-equity ratio of 3.74. The firm has a market cap of £482.58 million, a P/E ratio of 4,500.00, a P/E/G ratio of 5.00 and a beta of 0.74. Advanced Medical Solutions Group has a twelve month low of GBX 171.60 ($2.27) and a twelve month high of GBX 275.83 ($3.64).

Advanced Medical Solutions Group Cuts Dividend

The firm also recently declared a dividend, which will be paid on Friday, October 25th. Stockholders of record on Thursday, September 26th will be given a dividend of GBX 0.77 ($0.01) per share. This represents a dividend yield of 0.32%. The ex-dividend date is Thursday, September 26th. Advanced Medical Solutions Group’s payout ratio is presently 4,000.00%.

About Advanced Medical Solutions Group

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare.